Cargando…
COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption
Since the outbreak of COVID-19, clinicians have tried every effort to fight the disease, and multiple drugs have been proposed. However, no proven effective therapies currently exist, and different clinical phenotypes complicate the situation. In clinical practice, many severe or critically ill COVI...
Autores principales: | Nisoli, Enzo, Cinti, Saverio, Valerio, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369504/ https://www.ncbi.nlm.nih.gov/pubmed/32691334 http://dx.doi.org/10.1007/s40519-020-00963-y |
Ejemplares similares
-
COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity
por: Cinti, Saverio, et al.
Publicado: (2020) -
HARTNUP DISEASE
por: Patel, A B, et al.
Publicado: (2008) -
Hartnup Disease Masked by Kwashiorkor
por: Orbak, Zerrin, et al.
Publicado: (2010) -
Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control
por: Bifari, Francesco, et al.
Publicado: (2017) -
Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective
por: Valerio, Alessandra, et al.
Publicado: (2011)